In summary, we have shown that the decreased expression or activation of key survival molecules following treatment with PI3 Kinase/mTOR inhibitor PI-103 or HSP90 inhibitor 17-AAG in combination with TRAIL was associated with enhanced apoptosis in TRAIL-resistant colorectal cancer cells. The gene discussed is TNFSF10; the disease is colorectal cancer.